Riverside Strategic Capital Fund I v. CLG Investments

2025 Tex. Bus. 35
Texas Business Court·Decided September 17, 2025·No. 25-BC01B-0006·Published·Cited by 1 cases

Opinion

FILED IN

BUSINESS COURT OF TEXAS

BEVERLY CRUMLEY, CLERK

ENTERED

2025 Tex. Bus. 35 9/17/2025

The Business Court of Texas, 1st Division

RIVERSIDE STRATEGIC § CAPITAL FUND I, L.P.; RSCF § BLOCKER TRUE HEALTH, LLC; § and RSCF I-A BLOCKER TRUE § HEALTH, LLC, Plaintiffs § v. § Cause No. 25-BC01B-0006 §

CLG INVESTMENTS, LLC; § CHRISTOPHER § GROTTENTHALER; COVERT § INVESTMENT OPERATIONS, § LLC; TRUE HEALTH § DIAGNOSTIC MANAGEMENT § LLC; L. RICHARD COVERT; LCG § VENTURES II, LLC; FERNANDO § DE LEON; TIMOTHY § TATROWICZ ALBA DURATA, § LLC; TOM D. WIPPMAN, in his § capacity as trustee of the Tom D. § Wippman Revocable Trust; MARK § THOMAS SMITH; ALEXANDRA § NETTESHEIM; KYLE § NETTESHEIM; ROBERT J. § OSTERHOFF; RJ § INVESTMENTS; MATT § MILBURN; MICHAEL A.

CLEMENTS; MICHAEL § OSTERHOFF; MELINDA L. § MILBURN; KAREN A. MILLER; § JACK NOVAK; EDWARD § MCCAN; DANIEL § GROTTENTHALER; ANITA § GROTTENTHALER; DANA M. § HOVIND; CHRISTIAN § RICHARDS; CHRISTOPHER W. § KLING; in his capacity as trustee § of Christopher W. & Marissa M. § Kling Rev Trust u/a/d 5/11/2012; § KEVIN M. NELLIS; CAROL A. § NELLIS; BRUCE ZIVIAN; RYAN § NELLIS; and ANCELMO E. § LOPES, Defendants §

═══════════════════════════════════════ OPINION

═══════════════════════════════════════

Syllabus 1

This opinion addresses when statutes of limitations accrue and the application of the discovery rule and fraudulent concealment principles regarding claims of fraudulent statements contained in a securities purchase agreement.

1 The syllabus was created by court staff and is provided for the reader’s convenience. It is not part of the court’s opinion, does not constitute the court’s official description or statement, and should not be relied upon as legal authority.

I. OPINION

[¶ 1] This fraud case arises out of a securities purchase agreement.

Plaintiffs invested into a healthcare company that provided laboratory management and diagnostic services. They allege that the defendants made false representations regarding the company’s compliance with applicable laws.

[¶ 2] Plaintiffs sued the defendants for (i) fraud, (ii) money had and received, and (iii) conspiracy.

[¶ 3] Defendants moved for traditional summary judgment arguing that statutes of limitations bar plaintiffs’ causes of action. The outcome rests on when plaintiffs knew, or should have known through the exercise of reasonable diligence, facts giving rise to their causes of action.

[¶ 4] The summary judgment evidence conclusively establishes that plaintiffs were aware of facts, conditions, or circumstances more than four years before filing suit that would cause a reasonably prudent person to make an inquiry that if pursued would have led them to discover their causes of action. This inquiry notice is legally equivalent to knowledge of the causes of action. Thus, plaintiffs’ claims are barred because they failed to sue within the limitations period. Further, they failed to raise a genuine issue of material fact

regarding fraudulent concealment.

II. JURISDICTION AND VENUE

[¶ 5] This court has subject matter jurisdiction because this is an action arising out of a qualified transaction and the amount in controversy exceeds $10 million. TEX. GOV’T CODE § 25.A.004(d)(1).2 The court also has jurisdiction under TEX. GOV’T CODE § 25.A.004(b)(2) because this is an action regarding the internal affairs of an organization and the amount in controversy exceeds $5 million. TEX. GOV’T CODE § 25.A.004(b)(2).

III. THE SUMMARY JUDGMENT RECORD

[¶ 6] The court considered the pleadings, summary judgment submissions, and related oral arguments.

IV. FACTS

A. The Parties and Related Entities

[¶ 7] True Health Group LLC provided laboratory management and diagnostic services for the healthcare industry.3 Plaintiffs invested in True

2 Effective September 1, 2025, the legislature lowered the qualified transaction monetary threshold from $10 million to $5 million. See Tex. H.B. 40, 89th Leg., R.S. (2025). However, plaintiffs filed this suit before that change became effective. So, the $10 million threshold applies to this case.

3 Plaintiffs’ Original Petition (Pet.) ¶ 1.

Health. Defendants were “significant equityholders” in True Health.4

[¶ 8] Plaintiff Riverside Strategic Capital Fund I L.P. is a Delaware limited partnership investment fund.5

[¶ 9] Plaintiffs RSCF Blocker True Health, LLC and RSCF I-A Blocker True Health, LLC are Delaware limited liability companies that Riverside used to structure its investment in True Health.6 B. Investigations and Proceedings Against THD

[¶ 10] In March of 2014, Christopher Grottenthaler founded True Health Diagnostics (THD), True Health’s predecessor. 7

[¶ 11] In 2015, THD purchased the assets of another laboratory company called Health Diagnostics Laboratory, Inc. (HDL). 8 Prior to the acquisition, HDL was allegedly driven out of business because of pervasive healthcare fraud. 9

[¶ 12] In November of 2015, THD signed a laboratory processing

4 Pet. ¶ 1. The parties’ agreement defines “significant equity holders” to mean “the members of the Company set forth on the signature pages” thereto. Securities Purchase Agreement (SPA) at Preamble (Defs’ 1 App. 0014).

5 Pet. ¶ 11.

6 Pet. ¶s 12–13.

7 Pet. ¶ 57.

8 Geren Declaration ¶ 4 (Defs’ 2 App. 0583).

9 Geren Declaration ¶ 4 (Defs’ 2 App. 0583); Trustee Lawsuit at 21 n.17 (Defs’ 2 App. 665).

agreement with Little River Healthcare (LRH). 10

[¶ 13] The next year, THD underwent a corporate reorganization and became True Health’s subsidiary.11

[¶ 14] Prior to Plaintiffs’ (Riverside) investment into True Health, the company had been accused in online articles of continuing the fraudulent activities that had resulted in HDL going out of business. 12 Riverside was aware of these articles.13

[¶ 15] On April 29, 2016, Cigna issued THD with a notice of claims review and audit. 14

[¶ 16] A few days later, United Healthcare halted laboratory claim reimbursements to THD due to compliance concerns.15

[¶ 17] Later that year, Medicare investigators visited True Health’s headquarters, requested documents, placed several referring physicians on prepayment review, and commenced a billing audit.16

[¶ 18] On January 26, 2017, Riverside invested $50 million into True

10 Pet. ¶ 57.

11 Pet. ¶ 62.

12 See Pls’ 2 App. 255–59.

13 Greenberg Depo. at 282:5–284:23 (Defs’ 2 App. 0548).

14 Trustee Lawsuit ¶ 129 (Defs’ 2 App. 0679).

15 Trustee Lawsuit ¶ 129 (Defs’ 2 App. 0679).

16 Trustee Lawsuit ¶ 128 (Defs’ 2 App. 0679).

Health in exchange for preferred True Health units and the right to buy more units on a diluted basis by executing the Securities Purchase Agreement (SPA) and Exchange Agreement.17 CLG Investment, LLC was appointed as the “Equityholders’ Representative” for the deal. Christopher Grottenthaler was at all relevant times CLG Investments, LLC’s managing member. 18 Further, as part of this deal, Riverside managing director Hal Greenberg became a True Health board member.19

[¶ 19] On March 2, 2017, the U.S. Department of Justice served True Health with a Civil Investigative Demand (CID) concerning possible Anti- Kickback Statute and Stark Law violations and other issues. 20

[¶ 20] Three months later, the Centers for Medicare & Medicaid Services (CMS) placed True Health on a 100% suspension of Medicare payments and provided a notice that the suspension was due to “credible allegations of fraud” regarding billing practices and claim submissions. 21

[¶ 21] However, a month later, CMS reduced the suspension to 35%.22

17 Pet. ¶ 63.

18 Pet. ¶ 64.

19 Greenberg Dep. 110:17–23 (Defs’ 2 App. 0539); Board Minutes (Defs’ 1 App.

0150).

20 CID (Defs’ 1 App. 0363–87).

21 Pet. ¶ 73; CMS Notice of First Suspension (Defs’ 2 App. 0388-91).

22 Pet. ¶ 74; Zucker Declaration ¶ 18 (Defs’ 2 App. 0603).

[¶ 22] After the first CMS suspension, Riverside invested another $30 million into True Health to keep the company afloat and subsequently took control of the board in May of 2018. 23

Free access — add to your briefcase to read the full text and ask questions with AI

Riverside Strategic Capital Fund I v. CLG Investments, 2025 Tex. Bus. 35 (Tex. Super. Ct. 2025).

2025 Tex. Bus. 35 (Riverside Strategic Capital Fund I v. CLG Investments) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related